These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9011592)

  • 1. Detection of renal allograft rejection by complement components C5A and TCC in plasma and urine.
    Müller TF; Kraus M; Neumann C; Lange H
    J Lab Clin Med; 1997 Jan; 129(1):62-71. PubMed ID: 9011592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anaphylatoxin C5a, a new parameter in the diagnosis of renal allograft rejection.
    Müller TF; Neumann CM; Greb C; Kraus M; Lange H
    Transpl Int; 1996; 9 Suppl 1():S58-62. PubMed ID: 8959792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum hippuric acid concentration in renal allograft rejection, ureter obstruction, and tubular necrosis.
    Knoflach A; Binswanger U
    Transpl Int; 1994; 7(1):17-21. PubMed ID: 8117397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine.
    Tatapudi RR; Muthukumar T; Dadhania D; Ding R; Li B; Sharma VK; Lozada-Pastorio E; Seetharamu N; Hartono C; Serur D; Seshan SV; Kapur S; Hancock WW; Suthanthiran M
    Kidney Int; 2004 Jun; 65(6):2390-7. PubMed ID: 15149352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of urine cytology in the diagnosis of allograft rejection after combined pancreas-kidney transplantation.
    Radio SJ; Stratta RJ; Taylor RJ; Linder J
    Transplantation; 1993 Mar; 55(3):509-16. PubMed ID: 8384382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of complement split products in plasma and urine as biomarkers of kidney graft rejection.
    Gramkow AM; Isaksson GL; Palarasah Y; Jensen BL; Alnor A; Thiesson HC
    Immunobiology; 2023 Jul; 228(4):152462. PubMed ID: 37406469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical analysis of perioperative complement activity during ischemia/reperfusion injury following renal transplantation.
    Błogowski W; Dołęgowska B; Sałata D; Budkowska M; Domański L; Starzyńska T
    Clin J Am Soc Nephrol; 2012 Nov; 7(11):1843-51. PubMed ID: 22904122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of soluble adhesion molecules (sICAM-1, sVCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine. Clinical monitoring of renal allograft recipients.
    Bechtel U; Scheuer R; Landgraf R; König A; Feucht HE
    Transplantation; 1994 Oct; 58(8):905-11. PubMed ID: 7524208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional profiles in urine during acute rejection, bacteriuria, CMV infection and stable graft function after renal transplantation.
    Øzbay A; Tørring C; Olsen R; Carstens J
    Scand J Immunol; 2009 Apr; 69(4):357-65. PubMed ID: 19284501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary N-acetyl-beta-D-glucosaminidase and neopterin aid in the diagnosis of rejection and acute tubular necrosis in initially nonfunctioning kidney grafts.
    Kotanko P; Margreiter R; Pfaller W
    Nephron; 2000 Mar; 84(3):228-35. PubMed ID: 10720893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient.
    Damman J; Seelen MA; Moers C; Daha MR; Rahmel A; Leuvenink HG; Paul A; Pirenne J; Ploeg RJ
    Transplantation; 2011 Jul; 92(2):163-9. PubMed ID: 21677599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney.
    van Werkhoven MB; Damman J; Daha MR; Krikke C; van Goor H; van Son WJ; Hillebrands JL; van Dijk MC; Seelen MA
    Mol Immunol; 2013 Mar; 53(3):237-45. PubMed ID: 22960554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined assay of soluble CD30 and hepatocyte growth factor for diagnosis of acute renal allograft rejection].
    Li CJ; Yu LX; Xu J; Fu SJ; Deng WF; Du CF; Wang YB
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):241-2. PubMed ID: 18250052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
    Sarwal MM; Cecka JM; Millan MT; Salvatierra O
    Transplantation; 2000 Dec; 70(12):1728-36. PubMed ID: 11152105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients.
    Krongvorakul J; Kantachuvesiri S; Ingsathit A; Rattanasiri S; Mongkolsuk T; Kitpoka P; Thammanichanond D
    Asian Pac J Allergy Immunol; 2015 Jun; 33(2):117-22. PubMed ID: 26141032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor production during human renal allograft rejection is associated with depression of plasma protein C and free protein S levels and decreased intragraft thrombomodulin expression.
    Tsuchida A; Salem H; Thomson N; Hancock WW
    J Exp Med; 1992 Jan; 175(1):81-90. PubMed ID: 1309855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of adhesion molecule expression by tubular epithelial cells using urine immunocytology.
    Chan RD; Greenstein SM; Sablay L; Alfonso F; Tellis V; Spitzer A; Greifer I; Corey HE
    Acta Cytol; 1995; 39(3):435-42. PubMed ID: 7762329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of acute renal allograft rejection in early post-transplantation period by soluble CD30.
    Dong W; Shunliang Y; Weizhen W; Qinghua W; Zhangxin Z; Jianming T; He W
    Transpl Immunol; 2006 Jun; 16(1):41-5. PubMed ID: 16701175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
    Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
    Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 and neopterin in renal transplant recipients: a longitudinal study.
    Raasveld MH; Bloemena E; Wilmink JM; Surachno S; Schellekens PT; ten Berge RJ
    Transpl Int; 1993 Mar; 6(2):89-94. PubMed ID: 8383495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.